Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

Anti-NKG2A / CD94 Reference Antibody (monalizumab)

Produktgrößen
100 ug
£385,00
CHA310-100UG
1 mg
£965,00
CHA310-1MG
Über dieses Produkt
SKU:
CHA310
Zusätzliche Namen:
monalizumab
Anwendung:
Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
Buffer:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Klonalität:
Recombinant Monoclonal
Konzentration:
1 mg/ml
Weitere Details:
Anti-NKG2A / CD159a Reference Antibody (monalizumab)(CHA310) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Immunogen:
NKG2A / CD94
Isotyp:
IgG4
Physischer Zustand:
Lyophilized
Reinheit:
>95%
Reaktivitäten:
Human
Sequenz:
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK
Versandbedingungen:
Blue Ice
Spezifität:
NKG2A / CD94
Lagerbedingungen:
2-8[o]C, -70[o]C Avoid freeze/thaw cycles.
Hersteller:
Sanyou Biopharmaceuticals
Typ:
Antibody: Biosimilar Antibody
  • Datenblatt des Herstellers:CHA310
Anti-NKG2A / CD159a Reference Antibody (monalizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
The purity of Anti-NKG2A / CD159a Reference Antibody (monalizumab) is more than 95%, determined by SEC-HPLC.
Human NKG2A / CD159a HEK293 cells were stained with Anti-NKG2A / CD94 Reference Antibody (monalizumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.0409 ug/mL.
Anti-NKG2A / CD159a Reference Antibody (monalizumab) FACS Blocking was evaluated using human NKG2A/CD94 HEK293 cells. The IC50 was approximately 0.2162 nM.
Anti-NKG2A / CD159a Reference Antibody (monalizumab) Luciferase Assay was evaluated using Human NKG2A / CD159a HEK293. The EC50 was approximately 0.5236 nM.